TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)
$31.26 -0.35 (-1.1072%)
Analysed TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) News Sources
How Teva Pharmaceutical Industries (TEVA) Story Is Shifting With Duvakitug R&D And Biosimilars
17-04-2026
yahoo.com
J&J Targets Double-Digit Growth by 2030 Despite Stelara Drag
16-04-2026
yahoo.com
Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners
15-04-2026
yahoo.com
J&J Beats Q1 Earnings & Sales Estimates, Raises 2026 Outlook
14-04-2026
yahoo.com
Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable Clinics
14-04-2026
yahoo.com
BofA Raises its Price Target on Teva Pharmaceutical (TEVA) to $42
12-04-2026
yahoo.com
How The Corcept Therapeutics (CORT) Investment Story Is Shifting After Legal And Regulatory Updates
12-04-2026
yahoo.com
AMRX: 3 Growth Drivers Behind Amneal's 2026 Outlook
10-04-2026
yahoo.com
Is AMRX Stock Undervalued? Sales Multiple, Target, Upside
10-04-2026
yahoo.com
Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing
10-04-2026
yahoo.com
What is the current price of TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)?
The current price of TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) is $31.26.
TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) absolute price change since previous trading day?
The absolute price change of TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) since the previous trading day is $-0.35.
TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) percentage price change since previous trading day?
The percentage price change of TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) since the previous trading day is -1.1072%.
What is the most recent average sentiment score for TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)?
The most recent average sentiment score for TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) is 72 out of 100.
What is the most recent average sentiment for TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)?
The most recent sentiment for TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE) is .
SEC-8K** Filing Available For TEVA PHARMACEUTICAL-SP ADR (TEVA:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.